DZ Bank’s Idexx Laboratories IDXX Stock Holding History

DZ Bank’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Sell	427 -2,682	-86%	-$1.5M	﹤0.01%	906
2026 Q1	$1.75M	Sell	3,109 -10,437	-77%	-$6.69M	﹤0.01%	645
2025 Q4	$9.17M	Buy	13,546 +11,366	+521%	+$7.74M	0.01%	390
2025 Q3	$1.39M	Sell	2,180 -403	-16%	-$245K	﹤0.01%	669
2025 Q2	$1.39M	Sell	2,583 -5,057	-66%	-$2.42M	﹤0.01%	639
2025 Q1	$3.21M	Buy	7,640 +3,604	+89%	+$1.56M	﹤0.01%	511
2024 Q4	$1.67M	Sell	4,036 -2,619	-39%	-$1.15M	﹤0.01%	589
2024 Q3	$3.36M	Sell	6,655 -227	-3%	-$110K	﹤0.01%	521
2024 Q2	$3.35M	Sell	6,882 -1,576	-19%	-$791K	﹤0.01%	522
2024 Q1	$4.57M	Sell	8,458 -756	-8%	-$413K	﹤0.01%	487
2023 Q4	$5.11M	Sell	9,214 -2,699	-23%	-$1.27M	0.01%	454
2023 Q3	$5.21M	Buy	11,913 +2,858	+32%	+$1.43M	0.01%	446
2023 Q2	$4.55M	Buy	9,055 +5,955	+192%	+$2.85M	0.01%	476
2023 Q1	$1.55M	Buy	3,100 +2,702	+679%	+$1.29M	﹤0.01%	617
2022 Q4	$163K	Sell	398 -438	-52%	-$170K	﹤0.01%	879
2022 Q3	$272K	Sell	836 -3,007	-78%	-$1.1M	﹤0.01%	832
2022 Q2	$1.35M	Sell	3,843 -51,674	-93%	-$21.1M	﹤0.01%	679
2022 Q1	$30.4M	Sell	55,517 -12,707	-19%	-$6.68M	0.05%	223
2021 Q4	$45.1M	Buy	68,224 +37,041	+119%	+$23.3M	0.06%	176
2021 Q3	$19.4M	Sell	31,183 -16,373	-34%	-$11M	0.03%	279
2021 Q2	$30M	Buy	47,556 +3,361	+8%	+$1.86M	0.05%	216
2021 Q1	$21.6M	Buy	44,195 +7,075	+19%	+$3.54M	0.04%	246
2020 Q4	$18.5M	Buy	37,120 +17,010	+85%	+$7.61M	0.04%	245
2020 Q3	$7.91M	Buy	20,110 +7,525	+60%	+$2.78M	0.02%	323
2020 Q2	$4.16M	Buy	12,585 +285	+2%	+$82.5K	0.01%	375
2020 Q1	$2.98M	Sell	12,300 -346	-3%	-$90.3K	0.01%	388
2019 Q4	$3.31M	Buy	12,646 +10,644	+532%	+$2.8M	0.01%	424
2019 Q3	$544K	Hold	2,002	–	–	﹤0.01%	584
2019 Q2	$551K	Buy	2,002 +138	+7%	+$34K	﹤0.01%	600
2019 Q1	$416K	Buy	1,864 +642	+53%	+$133K	﹤0.01%	606
2018 Q4	$227K	Hold	1,222	–	–	﹤0.01%	643
2018 Q3	$305K	Sell	1,222 -5,303	-81%	-$1.29M	﹤0.01%	639
2018 Q2	$1.42M	Sell	6,525 -7,095	-52%	-$1.46M	0.01%	527
2018 Q1	$2.61M	Buy	13,620 +4,752	+54%	+$877K	0.01%	509
2017 Q4	$1.39M	Sell	8,868 -913	-9%	-$144K	0.01%	521
2017 Q3	$1.52M	Sell	9,781 -3,994	-29%	-$631K	0.01%	517
2017 Q2	$2.22M	Buy	13,775 +4,252	+45%	+$691K	0.01%	471
2017 Q1	$1.47M	Buy	9,523 +2,794	+42%	+$385K	0.01%	517
2016 Q4	$789K	Buy	+6,729	New	+$768K	﹤0.01%	570

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

DZ Bank's IDXX Position: Q2 2026 in Review

DZ Bank reduced its Idexx Laboratories (IDXX) stake by 86% in Q2 2026, selling an estimated $1.5M and leaving 427 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #906.

DZ Bank first reported a position in IDXX in Q4 2016 and has held it in 39 quarters since. The position peaked at $45.1M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

DZ Bank held 427 shares of Idexx Laboratories worth $225K as of Q2 2026.
DZ Bank sold 2,682 Idexx Laboratories shares in Q2 2026, an estimated $1.5M.
Idexx Laboratories made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #906 holding.
DZ Bank first reported a position in Idexx Laboratories in Q4 2016 and has held it in 39 quarters since.
DZ Bank's Idexx Laboratories position peaked at $45.1M in Q4 2021.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.